Astra Biotech has developed an osteoporosis diagnostic test kit to improve the identification of defects that result in abnormalities in bone matrix mineralisation.
The kit uses RT-PCR for the detection of polymorphisms in the Colia1 and VDR genes.
The osteoporosis assay tests both polymorphisms and is more sensitive and convenient than alternative assays, according to the company.
The kit includes all the necessary primers, enzymes, positive controls and buffers sufficient for 100 assays.
The osteoporosis assay is produced following strict quality control procedures and using only certified high-purity reagents.
It is IVD compliant and therefore suitable for clinical applications.
